help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1538
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/1/192    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ulinski, T.
Right arrow Articles by Giurgea, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ulinski, T.
Right arrow Articles by Giurgea, I.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Medline Plus Health Information
*Kidney Transplantation
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Diabetes and Insulin
Right arrow Thyroid
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 1 192-195
Copyright © 2006 by The Endocrine Society

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome with Renal Failure: Impact of Posttransplant Immunosuppression on Disease Activity

Tim Ulinski, Laurence Perrin, Michael Morris, Muriel Houang, Sylvie Cabrol, Christine Grapin, Nathalie Chabbert-Buffet, Albert Bensman, Georges Deschênes and Irina Giurgea

Departments of Pediatric Nephrology (T.U., L.P., A.B., G.D.), Pediatric Endocrinology (M.H., S.C.), and Pediatric Surgery (C.G.), Hôpital Trousseau, 75571 Paris Cedex 12, France; Division of Medical Genetics (M.M.), Centre Medical Universitaire, 1121 Genève, Switzerland; Department of Endocrinology and Diabetes (N.C.-B.), Hôpital Tenon, F-75970 Paris Cedex 20, France; and Department of Genetics (I.G.), Hôpital Henri Mondor, 94010 Créteil, France

Address all correspondence and requests for reprints to: T. Ulinski, Department of Pediatric Nephrology; Hôpital Trousseau; 26, avenue du Dr. Arnold-Netter; 75571 Paris Cedex 12, France. E-mail: tim.ulinski{at}trs.aphp.fr.

Context: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autosomal recessive disorder caused by mutations in the gene AIRE (autoimmune regulator). APECED affects mainly endocrine organs resulting in hypoparathyroidism, adrenocortical failure, diabetes mellitus, hypogonadism, and hypothyroidism. Nonendocrine organ manifestations are autoimmune hepatitis, vitiligo, pernicious anemia, exocrine pancreatic insufficiency, and alopecia. APECED’s first manifestation generally is mucocutaneous candidiasis presumably related to T cell dysfunction.

Patient: A 5-yr-old Iranian girl presented first with pernicious anemia, exocrine pancreatic insufficiency, and nail candidiasis. She had renal dysfunction due to chronic interstitial nephritis (CIN), which progressed to end-stage renal failure. She was transplanted 1 yr later. Common causes of CIN were excluded. APECED was suspected first because she developed progressively hypoparathyroidism, adrenocortical failure, glucose intolerance, and hypothyroidism.

Results: Genetic analysis revealed a large homozygous deletion (g.424_2157del1734), spanning exons 2–4, in the AIRE gene. The predicted protein, if it is produced, has only 44 amino acids (exon 1) in common with the wild-type protein. Immunosuppression after the first renal transplant included prednisone, azathioprine, and cyclosporine A. Multiple acute rejection episodes occurred. Chronic rejection resulted in lost graft and she was retransplanted 2 yr later. Surprisingly, all APECED-related symptoms including candidiasis and autoantibody levels decreased, presumably due to the reinforced immunosuppression (tacrolimus, mycophenolate mofetil, prednisone).

Conclusions: This is the first report of an APECED patient with CIN resulting in end-stage renal failure. Clinical and biological improvement was observed under posttransplant multidrug immunosuppression including tacrolimus and mycophenolate mofetil.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. J. DeVoss, A. K. Shum, K. P. A. Johannes, W. Lu, A. K. Krawisz, P. Wang, T. Yang, N. P. LeClair, C. Austin, E. C. Strauss, et al.
Effector Mechanisms of the Autoimmune Syndrome in the Murine Model of Autoimmune Polyglandular Syndrome Type 1
J. Immunol., September 15, 2008; 181(6): 4072 - 4079.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Perheentupa
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2843 - 2850.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society